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Introduction
Venous sinus stent insertion is being increasingly used
as a primary treatment for intracranial hypertension
patients (BIH). However, the value of this treatment
modality is still controversial. This study looks into the
difference in effectiveness of stents inserted as a primary
procedure and those inserted in patients who already
had cerebrospinal fluid diverting shunt in place i.e. as a
secondary procedure.
Materials and methods
A retrospective case series of patients with intracranial
hypertension treated in our unit with venous sinus stent
insertion. Case notes were reviewed for clinical presen-
tation, initial response to stent insertion and follow up
results. Patients in group A did not have previous shunt
before insertion of stent (stent as primary procedure)
while group B patients already had shunt(s) in situ
(stent as secondary procedure). Stent survival time was
defined as number of days from stent insertion until the
next intervention due to worsening/recurrent symptoms
or end of follow up period (June 2015).
Results
In total, 44 patients underwent stent insertion between
2011 and 2015 (24 patients in group A and 20 in group B).
Follow-up period was 490 ± 453 days (mean +standard
deviation); group A 548 ±522 days and group B 420 ±488
days (p=0.6). The stent survival time in group A was 435 ±
453 days compared with group B: 270.95 ± 394.86 days
(p= 0.03). A total of 13 patients required further surgical
intervention during the follow up period, of which 4 (16%)
were in group A and 9 (45%) in group B (p=0.001).
Discussion
The results suggest that stent insertion is a relatively effec-
tive method of treatment of patients with intracranial
hypertension. Lower survival rates of stents inserted as a
secondary procedure could be related to the fact that
shunts change the cerebrospinal fluid hydrodynamics
interfering with stent function or simply due to the fact
that group B patients have more aggressive form of intra-
cranial hypertension.
Published: 18 September 2015
doi:10.1186/2045-8118-12-S1-P46
Cite this article as: Shah et al.: Cerebral venous sinus stent insertion as
a primary versus secondary procedure in the treatment of intracranial
hypertension. Fluids and Barriers of the CNS 2015 12(Suppl 1):P46.
* Correspondence: syed.shah9@live.co.uk
National Hospital for Neurology and Neurosurgery (NHNN), UCLH, UK
Shah et al. Fluids and Barriers of the CNS 2015, 12(Suppl 1):P46
http://www.fluidsbarrierscns.com/content/12/S1/P46
FLUIDS AND BARRIERS 
OF THE CNS
© 2015 Shah et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
